Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 7:29 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1249–1272 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Diabetic Foot Ulcers
Interventions: Prevention Diabetic Foot Ulcer; Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2002
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Voice Disorders, Gastroesophageal Reflux
Interventions: Neuromuscular Electrical Stimulation, Unstimulated; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 6 Years to 11 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Diabetic Foot Ulcers (DFUs), Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer)
Interventions: Miro3D Wound Matrix, Standard of Care (SOC); Device · Other
Lead sponsor: Reprise Biomedical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 3
States / cities: Coconut Creek, Florida • Tamarac, Florida • New York, New York

Conditions: Diabetic Foot Ulcers
Interventions: AMNIOEXCEL, Standard of Care, Diabetic Foot Ulcers; Other
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 8
States / cities: Phoenix, Arizona • Castro Valley, California • Stockton, California + 5 more

Conditions: Ulcerative Colitis
Interventions: Tauroursoursodeoxycholic acid, brand name Tudcabil; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: Creve Coeur, Missouri • St Louis, Missouri

Conditions: Partial-thickness Burn, Ulcer
Interventions: NPWT PRO without irrigation, NPWT PRO with irrigation, KCI Ulta; Device
Lead sponsor: Larry Lavery; Other
Eligibility: 18 Years to 89 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis
Interventions: Not listed
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Skin Ulcers, Sickle Cell Anemia
Interventions: Arginine Butyrate, Standard local care dressing; Drug · Other
Lead sponsor: Susan P. Perrine; Other
Eligibility: 16 Years to 60 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2005
U.S. locations: 4
States / cities: Chicago, Illinois • Boston, Massachusetts • New York, New York + 1 more

Conditions: Diabetic Foot Ulcers
Interventions: acoustical pulse energy (extracorporeal shockwave), Sham; Device · Other
Lead sponsor: SANUWAVE, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 21
States / cities: Phoenix, Arizona • Tucson, Arizona • Castro Valley, California + 16 more

Conditions: Diabetic Foot Ulcers
Interventions: type of footwear, collagen dressing with and without silver; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Diabetic Complications
Interventions: Prontosan, Saline; Device
Lead sponsor: B. Braun Medical Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 2
States / cities: San Diego, California • Chicago, Illinois

Conditions: Ulcerative Colitis
Interventions: Adalimumab; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 3
States / cities: Scottsdale, Arizona • Chicago, Illinois • Rochester, Minnesota

Conditions: Foot Ulcer
Interventions: Collagen ORC Antimicrobial Matrix (CAM); Device
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 48 participants
Timeline: 2004 – 2005
U.S. locations: 3
States / cities: Fort Lauderdale, Florida • South Miami, Florida • Warren, Pennsylvania

Conditions: Ulcerative Colitis
Interventions: mesalamine; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 44
States / cities: Birmingham, Alabama • Anaheim, California • Sacramento, California + 41 more

Conditions: Venous Leg Ulcer, Chronic Wounds
Interventions: Hyalomatrix, Standard of Care; Device · Other
Lead sponsor: NuScience Medical Biologics, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Alexandria, Louisiana • Pineville, Louisiana • Vidalia, Louisiana + 1 more

Conditions: Ulcerative Colitis, Pouchitis
Interventions: ursodiol (ursodeoxycholic acid, UDCA); Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pyoderma Gangrenosum
Interventions: Bimekizumab; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Ulcerative Colitis
Interventions: Adalimumab, Placebo; Biological
Lead sponsor: AbbVie; Industry
Eligibility: 4 Years to 17 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 16
States / cities: Los Angeles, California • San Francisco, California • Orlando, Florida + 11 more

Conditions: Foot Ulcer, Diabetic
Interventions: Quantum™ Therapy - NPWT with Prontosan, Quantum™ Therapy; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Diabetic Foot Ulcers
Interventions: Electrohydraulic-generated shock wave, Sham device plus standard of care; Device
Lead sponsor: SANUWAVE, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 18
States / cities: Phoenix, Arizona • Tucson, Arizona • Long Beach, California + 12 more

Conditions: Corneal Ulcer, Eye Infections, Fungal
Interventions: Natamycin, Voriconazole; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 16 Years and older
Enrollment: 323 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Inflammatory Bowel Diseases
Interventions: Blood Draw, Urine Collection, Stool Collection; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2065
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Ulcerative Colitis
Interventions: Ontamalimab, Placebo; Drug · Other
Lead sponsor: Shire; Industry
Eligibility: 16 Years to 80 Years
Enrollment: 380 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 38
States / cities: Little Rock, Arkansas • Lancaster, California • Rialto, California + 31 more

Conditions: Diabetic Foot Ulcer
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 455 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk

Quantifying Effects of Treatment of Pediatric Dysphonia

Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing

Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers

TUDCA as a Therapy for Ulcerative Colitis (UC)

NPWT PRO vs KCI Ulta® NPWT and to Compare NPWT PRO vs NPWT PRO With Simultaneous Irrigation on Wound Healing

The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness

Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers

Effectiveness of dermaPACE™ Device and Standard Treatment Compared to Standard Treatment Alone for Diabetic Foot Ulcers

Developing a Diabetic Foot Ulcer Protocol

Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients

Open-Label Adalimumab for Ulcerative Colitis Patients

Evaluation of the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)

Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers

The Role of Secondary Bile Acids in Intestinal Inflammation

Efficacy of Bimekizumab in Adults With Pyoderma Gangrenosum

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis

Negative Pressure Wound Therapy as a Drug Delivery System (ADANPWT)

A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers

Mycotic Ulcer Treatment Trial I

Mayo Clinic IBD Biobank

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

Inflammatory Biomarkers to Diagnose and Monitor Diabetic Foot Osteomyelitis